Study schema. All patients underwent leukapheresis > 2 weeks before initiating therapy to harvest DC progenitors. Treatment protocol consisted of 3 cycles of lenalidomide (10 mg/d) for 3 weeks followed by 1 week of rest. KRN7000 DCs were infused on day 7 of each cycle.